These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31281537)

  • 1. Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling.
    Zou Q; Xiao Z; Huang R; Wang X; Wang X; Zhao H; Yang X
    Theranostics; 2019; 9(14):4141-4155. PubMed ID: 31281537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo annotation and characterization of the translatome with ribosome profiling data.
    Xiao Z; Huang R; Xing X; Chen Y; Deng H; Yang X
    Nucleic Acids Res; 2018 Jun; 46(10):e61. PubMed ID: 29538776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RiboMiner: a toolset for mining multi-dimensional features of the translatome with ribosome profiling data.
    Li F; Xing X; Xiao Z; Xu G; Yang X
    BMC Bioinformatics; 2020 Aug; 21(1):340. PubMed ID: 32738892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome Profiling.
    Gerresheim GK; Bathke J; Michel AM; Andreev DE; Shalamova LA; Rossbach O; Hu P; Glebe D; Fricke M; Marz M; Goesmann A; Kiniry SJ; Baranov PV; Shatsky IN; Niepmann M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translatome profiling: methods for genome-scale analysis of mRNA translation.
    King HA; Gerber AP
    Brief Funct Genomics; 2016 Jan; 15(1):22-31. PubMed ID: 25380596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative transcription start site selection in ACSS2 controls its nuclear localization and promotes ribosome biosynthesis in hepatocellular carcinoma.
    Wang YH; Huang S; Zhu L; Yang Q; Yang XM; Gu JR; Zhang ZG; Nie HZ; Li J
    Biochem Biophys Res Commun; 2019 Jun; 514(3):632-638. PubMed ID: 31076106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L; Shen AG; Wang GL; Lu P; Li XY
    Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosome Profiling Reveals Genome-wide Cellular Translational Regulation upon Heat Stress in Escherichia coli.
    Zhang Y; Xiao Z; Zou Q; Fang J; Wang Q; Yang X; Gao N
    Genomics Proteomics Bioinformatics; 2017 Oct; 15(5):324-330. PubMed ID: 29031842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
    Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
    Shyu YC; Lee TL; Lu MJ; Chen JR; Chien RN; Chen HY; Lin JF; Tsou AP; Chen YH; Hsieh CW; Huang TS
    J Transl Med; 2016 Jul; 14(1):200. PubMed ID: 27370270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi.
    Smircich P; Eastman G; Bispo S; Duhagon MA; Guerra-Slompo EP; Garat B; Goldenberg S; Munroe DJ; Dallagiovanna B; Holetz F; Sotelo-Silveira JR
    BMC Genomics; 2015 Jun; 16(1):443. PubMed ID: 26054634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.